T
Tracy A. Spalding
Researcher at ACADIA Pharmaceuticals Inc.
Publications - 2
Citations - 247
Tracy A. Spalding is an academic researcher from ACADIA Pharmaceuticals Inc.. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 2, co-authored 2 publications receiving 245 citations. Previous affiliations of Tracy A. Spalding include Pennsylvania State University.
Papers
More filters
Journal Article
5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics
D. M. Weiner,Ethan S. Burstein,Norman Nash,G. E. Croston,E. A. Currier,Kimberly E. Vanover,Scott C. Harvey,E. M. Donohue,H. C. Hansen,Carl-Magnus A. Andersson,Tracy A. Spalding,D. F. C. Gibson,Kirsten Krebs-Thomson,Susan B. Powell,Mark A. Geyer,Uli Hacksell,Mark R. Brann +16 more
TL;DR: Functional high-throughput screening of a diverse chemical library identified 530 ligands with inverse agonist activity at 5-HT2A receptors, including several series of compounds related to known antipsychotics, as well as a number of novel chemistries.
Journal ArticleDOI
Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypes.
Diane J. Ford,Anthony Essex,Anthony Essex,Tracy A. Spalding,Tracy A. Spalding,Ethan S. Burstein,Ethan S. Burstein,John Ellis +7 more
TL;DR: It is possible that TM6 represents a general switch for the activation of the muscarinic receptor family, and this mutation at the top of TM6 is a ligand-dependent switch that sets the activation state of the receptor.